Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Sun Pharma gets go-ahead in South Africa to sell generic semaglutide
Sun Pharma gets go-ahead in South Africa to sell generic semaglutide
BusinessLine

Drugmaker Sun Pharmaceutical Industries has received the green signal from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of semaglutide injection in South Africa for the treatment of…

fool.com - Jeff Siegel - Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
The Motley Fool

Drug pricing has been hanging over the pharmaceutical industry for years, and the Trump administration didn't eliminate that pressure. It did, however, pursue voluntary pricing agreements with many of the industry's largest drugmakers. Since late…

law360.com - Jarek Rutz - Pharma Cos. Clash In Del. Chancery Over Dental Drug License
Pharma Cos. Clash In Del. Chancery Over Dental Drug License
Law360

Ventis Pharma Inc. has sued Balanced Pharma Inc. in the Delaware Chancery Court, accusing its licensee of failing to make commercially reasonable efforts to develop and market a licensed dental anesthetic... To view the full article, register now.

siliconangle.com - Kyt Dotson - Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma
Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma
SiliconANGLE

Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in Series C funding, nearly tripling its valuation to $3.8 billion. Index…

thehindubusinessline.com - OneSource Specialty Pharma ties up with Germany's Formycon for Biosimilar manufacturing
OneSource Specialty Pharma ties up with Germany's Formycon for Biosimilar manufacturing
BusinessLine

OneSource Specialty Pharma Limited announced a strategic manufacturing partnership with Formycon AG, a Munich-based independent biosimilar developer, today. Under the agreement, OneSource will provide integrated Drug Substance and Drug Product…

thehindubusinessline.com - Natco Pharma raises Adcock Ingram stake to 49%, pays ₹1,060 crore
Natco Pharma raises Adcock Ingram stake to 49%, pays ₹1,060 crore
BusinessLine

Hyderabad-based Natco Pharma Limited on Tuesday completed the acquisition of an additional 13.25 per cent equity stake in South African pharmaceutical company Adcock Ingram Holdings Proprietary Limited, bringing its total shareholding to 49 per…

thehindu.com - Santosh V. Perumal - Why Semaglutide is an inflection point for India's generics sector?
Why Semaglutide is an inflection point for India's generics sector?
The Hindu

More than a supply chain issue and missing the first mover status, Semaglutide episode has rather exposed systemic chinks and could prove costly for India's pharmaceutical industry, which supplies about 20% of the world's generic medicines by…

fool.com - Adria Cimino - Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?
Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?
The Motley Fool

Eli Lilly (LLY 0.09%) and Novo Nordisk (NVO 0.35%) today participate in one of the most exciting growth markets in healthcare: the weight loss drug market, one that's on track to reach nearly $100 billion in a few years. Novo was the first to…

wsj.com - Peter Loftus - In the Weight-Loss Wars, Novo's Obesity Pill Is Pulling Way Ahead of Lilly's
In the Weight-Loss Wars, Novo's Obesity Pill Is Pulling Way Ahead of Lilly's
Wall Street Journal

The launch of weight-loss pills is the hottest battle in pharma. So far, is losing to rival. Since its obesity pill Foundayo hit the market in April, Lilly has captured about 11% of the prescription volume for new pills, according to the latest…

wsj.com - Alexander Hotz - The Race to Commercialize the World's Most Powerful Psychedelic
The Race to Commercialize the World's Most Powerful Psychedelic
Wall Street Journal

An obscure and extremely powerful psychedelic called 5-MeO-DMT is drawing intense interest from the pharmaceutical industry, where biotech companies are racing to turn it into a commercially available treatment for severe mental health disorders…

rediff.com - Rediff News - Sensex drops 561 points over West Asia flare-up
Sensex drops 561 points over West Asia flare-up
Rediff.com

Stock market benchmark indices Sensex and Nifty tumbled on Tuesday as a sharp surge in crude oil prices due to the renewed flare-up in West Asia dented investors' sentiment. Fresh foreign fund outflows and the falling rupee also put pressure on the…

cnbc.com - Joseph Wilkins - HSBC loses conviction in leading drugmaker, forecasts 'tough path' ahead
HSBC loses conviction in leading drugmaker, forecasts 'tough path' ahead
CNBC

HSBC has lost conviction in its buy rating for AstraZeneca and forecasts a 'tough path ahead' for the British-Swedish drugmaker, which last week posted a rare clinical trial failure that sent shares tumbling. The bank's analysts have downgraded the…

rediff.com - Nandita Malik - Sensex, Nifty Plunge: West Asia Tensions, Surging Crude Oil, Rupee Weakness Impact Indian Stocks
Sensex, Nifty Plunge: West Asia Tensions, Surging Crude Oil, Rupee Weakness Impact Indian Stocks
Rediff.com

Indian stock markets, including the Sensex and Nifty, witnessed a notable slump as escalating West Asia tensions drove crude oil prices sharply higher, alongside foreign fund outflows and a weakening rupee, impacting investor sentiment. Indian…

rediff.com - Rediff News - India, China trade rises to $91.72bn in first half of 2026
India, China trade rises to $91.72bn in first half of 2026
Rediff.com

China's exports to India increased by 21.8 per cent in the first half of 2026 to USD 79.41 billion, while Indian exports to China rose 37.2 per cent to USD 12.31 billion, according to data released by Chinese customs on Tuesday. The bilateral trade…

fool.com - David Jagielski, CPA - Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?
Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?
The Motley Fool

A high-yielding dividend may sound great for investors, but it can be a double-edged sword: when it's too high, investors start to worry about its safety. That's a big part of the reason why Pfizer (PFE 1.08%), whose 7.1% yield is well above the…

Receive a Daily briefing on Pharma Industry News

Get Started